BRIEF published on 04/30/2025 at 18:05, 1 year 5 months ago Neovacs fundraising: a 0.25 million euro operation Biotechnology Fundraising Shareholder Dilution Néovacs OCEANE-BSA
BRIEF published on 04/30/2025 at 18:05, 1 year 5 months ago Levée de fonds de Néovacs : une opération de 0,25 million d'euros Biotechnologie Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/30/2025 at 18:00, 1 year 5 months ago Levée de fonds de 0,25 MEUR Néovacs annonce levée fonds 0,25M€ par émission d'OCEANE-BSA pour financer recherche allergies et investir en Biotech/Medtech. Détails communiqués Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 6 months ago Fundraising of 0.25 Million Euros by Neovacs Fundraising Shareholder Dilution Biotech Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 6 months ago Levée de Fonds de 0,25 Million d'Euros par Néovacs Biotech Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/17/2025 at 18:30, 1 year 6 months ago Levée de fonds de 0,25 M EUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA destinée au développement de la recherche Kinoïde® sur les allergies et à l'investissement dans des projets prometteurs en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/16/2025 at 08:05, 1 year 6 months ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/16/2025 at 08:05, 1 year 6 months ago Néovacs s'exprime sur les rumeurs concernant le PXT3003 Biopharmaceutique PXT3003 Tasly Charcot-Marie-Tooth Autorisation Marché
PRESS RELEASE published on 04/16/2025 at 08:00, 1 year 6 months ago Néovacs fait le point sur des rumeurs Néovacs fait le point sur les rumeurs concernant l'autorisation de mise sur le marché de PXT3003 en Chine et l'impact potentiel sur ses actifs. Aucune confirmation disponible pour le moment Autorisation De Mise Sur Le Marché Néovacs PXT3003 Impact Potentiel Procédure De Liquidation
BRIEF published on 04/02/2025 at 20:05, 1 year 6 months ago Adjustment of the nominal value of Neovacs shares Shareholders Capital Reduction Dilutive Financing Nominal Value Néovacs
Published on 10/24/2026 at 00:04, 14 hours 40 minutes ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 15 hours 14 minutes ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 16 hours 49 minutes ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 22 hours 44 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 14:15, 28 minutes ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 14:15, 28 minutes ago Les lauréats des INPD Awards 2026 dévoilés : la beauté chinoise remporte plusieurs distinctions prestigieuses
Published on 10/24/2026 at 06:30, 8 hours 13 minutes ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 19 hours 48 minutes ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 20 hours 43 minutes ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 18 hours 10 minutes ago Déclaration hebdomadaire d'opérations effectuées du 19 au 23 octobre 2026
Published on 10/23/2026 at 20:33, 18 hours 10 minutes ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 20 hours 59 minutes ago Imerys-10-2026-communique-capital-droits-de-vote-au-30-septembre-2026
Published on 10/23/2026 at 17:45, 20 hours 59 minutes ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
